Assertion: hyperkalemia | /r/CapableOf | recur in patient
Facets:
Source sentences:
text: During the maintenance phase, both the 5-g and 10-g daily doses of ZS-9 were significantly superior to placebo in maintaining normokalemia (P=0.008 and P<0.001, respectively), with hyperkalemia recurring in patients assigned to placebo who had received 5 g or 10 g of ZS-9 during the initial phase (Figure 3B and 3C).